MyAverix Finance
SHG · Healthcare
Shanghai Rightongene Biotechnology Co. Ltd. A (688217)
Biotechnology
Shanghai Rightongene Biotechnology Co. Ltd. A (688217) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $1.55B, P/E ratio is 18.00, net margin is -28.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688217
Shanghai Rightongene Biotechnology Co. Ltd. A (688217) — FAQ
What is Shanghai Rightongene Biotechnology Co. Ltd. A's market cap?
Shanghai Rightongene Biotechnology Co. Ltd. A (688217) has a reported market cap of $1.55B (data as of 2026-03-29).
What is 688217's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Rightongene Biotechnology Co. Ltd. A (688217) is 18.00 (data as of 2026-03-29).
Does Shanghai Rightongene Biotechnology Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Rightongene Biotechnology Co. Ltd. A (688217). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Rightongene Biotechnology Co. Ltd. A in?
Shanghai Rightongene Biotechnology Co. Ltd. A (688217) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688217 listed on?
688217 is listed on SHG.
What is Shanghai Rightongene Biotechnology Co. Ltd. A's net margin?
Shanghai Rightongene Biotechnology Co. Ltd. A (688217) reports a net margin of -28.7% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.